Diaverum AB, a leading provider in the renal care industry, is headquartered in Sweden (SE) and operates extensively across Europe, Latin America, and the Middle East. Founded in 1991, Diaverum has established itself as a pioneer in delivering high-quality dialysis services, focusing on patient-centred care and innovative treatment solutions. The company offers a range of services, including haemodialysis, peritoneal dialysis, and kidney care management, distinguished by its commitment to improving patient outcomes and enhancing quality of life. Diaverum's unique approach integrates advanced technology with personalised care, setting it apart in a competitive market. With a strong presence in over 20 countries, Diaverum has achieved significant milestones, including numerous awards for excellence in healthcare services. Its dedication to innovation and patient satisfaction solidifies its position as a trusted leader in renal care.
How does Diaverum AB's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Diaverum AB's score of 26 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Diaverum AB, headquartered in Sweden (SE), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established documented reduction targets or climate pledges, which suggests a lack of formal commitments to reduce its carbon footprint at this time. It is important to note that Diaverum AB is a current subsidiary and may inherit emissions data and climate initiatives from its parent organization. However, no specific details regarding such cascaded data or initiatives have been provided. In the context of the healthcare industry, where Diaverum operates, there is an increasing emphasis on sustainability and carbon reduction. Companies are encouraged to adopt science-based targets and engage in initiatives that align with global climate goals. As of now, Diaverum AB's climate commitments remain unspecified, highlighting an opportunity for the organisation to enhance its environmental strategy and transparency in emissions reporting.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Diaverum AB has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.